Azenta, Inc.AZTAEarnings & Financial Report
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
AZTA Q1 2026 Key Financial Metrics
Revenue
$148.6M
Gross Profit
$63.7M
Operating Profit
$-7.2M
Net Profit
$-15.4M
Gross Margin
42.9%
Operating Margin
-4.9%
Net Margin
-10.4%
YoY Growth
0.8%
EPS
$-0.34
Financial Flow
Azenta, Inc. Q1 2026 Financial Summary
Azenta, Inc. reported revenue of $148.6M (up 0.8% YoY) for Q1 2026, with a net profit of $-15.4M (down 15.7% YoY) (-10.4% margin). Cost of goods sold was $84.9M, operating expenses totaled $70.9M.
Key Financial Metrics
| Total Revenue | $148.6M |
|---|---|
| Net Profit | $-15.4M |
| Gross Margin | 42.9% |
| Operating Margin | -4.9% |
| Report Period | Q1 2026 |
Revenue Breakdown
Azenta, Inc. Q1 2026 revenue of $148.6M breaks down across 3 segments, led by Multiomics at $67.2M (45.2% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Multiomics | $67.2M | 45.2% |
| Core Products | $47.6M | 32.0% |
| Sample Repository Solutions | $33.8M | 22.8% |
Azenta, Inc. Revenue by Segment — Quarterly Trend
Azenta, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Multiomics and Core Products) has evolved quarter over quarter.
| Segment | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|
| Multiomics | $67.2M | $73.2M | $66.2M | $63.5M |
| Core Products | $47.6M | $54.2M | $45.8M | $48.0M |
| Sample Repository Solutions | $33.8M | $31.6M | $32.0M | $31.9M |
Azenta, Inc. Annual Revenue by Year
Azenta, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $593.8M). Click any linked year to see what changed vs the prior annual report.
Azenta, Inc. Quarterly Revenue & Net Profit History
Azenta, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 2026 | $148.6M | +0.8% | $-15.4M | -10.4% |
| Q4 2025 | $159.2M | +5.7% | $50.9M | 32.0% |
| Q3 2025 | $143.9M | -0.3% | $-48.0M | -33.4% |
| Q2 2025 | $143.3M | +5.1% | $-47.7M | -33.3% |
| Q1 2025 | $147.4M | +3.7% | $-11.0M | -7.5% |
| Q4 2024 | $150.6M | +156.3% | $-6.6M | -4.4% |
| Q3 2024 | $144.3M | -13.0% | $-6.6M | -4.5% |
| Q2 2024 | $136.4M | -8.1% | $-137.4M | -100.8% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $136.4M | $144.3M | $150.6M | $147.4M | $143.3M | $143.9M | $159.2M | $148.6M |
| YoY Growth | -8.1% | -13.0% | 156.3% | 3.7% | 5.1% | -0.3% | 5.7% | 0.8% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.56B | $2.32B | $2.10B | $2.04B | $2.03B | $2.02B | $2.06B | $2.07B |
| Liabilities | $340.6M | $332.9M | $332.4M | $322.6M | $338.6M | $346.0M | $332.6M | $359.6M |
| Equity | $2.22B | $1.99B | $1.77B | $1.72B | $1.70B | $1.67B | $1.73B | $1.71B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $8.7M | $9.8M | $17.7M | $29.8M | $14.4M | $25.8M | $2.2M | $20.8M |